10-Q 1 mrvl-20240803.htm FORM 10-Q mrvl-20240803
false2025Q2000183563202/01http://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent361270xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pure00018356322024-02-042024-08-0300018356322024-08-2300018356322024-08-0300018356322024-02-0300018356322024-05-052024-08-0300018356322023-04-302023-07-2900018356322023-01-292023-07-290001835632us-gaap:CommonStockMember2024-02-030001835632us-gaap:AdditionalPaidInCapitalMember2024-02-030001835632us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-02-030001835632us-gaap:RetainedEarningsMember2024-02-030001835632us-gaap:CommonStockMember2024-02-042024-05-040001835632us-gaap:AdditionalPaidInCapitalMember2024-02-042024-05-0400018356322024-02-042024-05-040001835632us-gaap:RetainedEarningsMember2024-02-042024-05-040001835632us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-02-042024-05-040001835632us-gaap:CommonStockMember2024-05-040001835632us-gaap:AdditionalPaidInCapitalMember2024-05-040001835632us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-05-040001835632us-gaap:RetainedEarningsMember2024-05-0400018356322024-05-040001835632us-gaap:CommonStockMember2024-05-052024-08-030001835632us-gaap:AdditionalPaidInCapitalMember2024-05-052024-08-030001835632us-gaap:RetainedEarningsMember2024-05-052024-08-030001835632us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-05-052024-08-030001835632us-gaap:CommonStockMember2024-08-030001835632us-gaap:AdditionalPaidInCapitalMember2024-08-030001835632us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-08-030001835632us-gaap:RetainedEarningsMember2024-08-030001835632us-gaap:CommonStockMember2023-01-280001835632us-gaap:AdditionalPaidInCapitalMember2023-01-280001835632us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-280001835632us-gaap:RetainedEarningsMember2023-01-2800018356322023-01-280001835632us-gaap:CommonStockMember2023-01-292023-04-290001835632us-gaap:AdditionalPaidInCapitalMember2023-01-292023-04-2900018356322023-01-292023-04-290001835632us-gaap:RetainedEarningsMember2023-01-292023-04-290001835632us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-292023-04-290001835632us-gaap:CommonStockMember2023-04-290001835632us-gaap:AdditionalPaidInCapitalMember2023-04-290001835632us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-290001835632us-gaap:RetainedEarningsMember2023-04-2900018356322023-04-290001835632us-gaap:CommonStockMember2023-04-302023-07-290001835632us-gaap:AdditionalPaidInCapitalMember2023-04-302023-07-290001835632us-gaap:RetainedEarningsMember2023-04-302023-07-290001835632us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-302023-07-290001835632us-gaap:CommonStockMember2023-07-290001835632us-gaap:AdditionalPaidInCapitalMember2023-07-290001835632us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-290001835632us-gaap:RetainedEarningsMember2023-07-2900018356322023-07-290001835632mrvl:DataCenterMember2024-05-052024-08-030001835632us-gaap:ProductConcentrationRiskMembermrvl:DataCenterMemberus-gaap:SalesRevenueNetMember2024-05-052024-08-030001835632mrvl:DataCenterMember2023-04-302023-07-290001835632us-gaap:ProductConcentrationRiskMembermrvl:DataCenterMemberus-gaap:SalesRevenueNetMember2023-04-302023-07-290001835632mrvl:DataCenterMember2024-02-042024-08-030001835632us-gaap:ProductConcentrationRiskMembermrvl:DataCenterMemberus-gaap:SalesRevenueNetMember2024-02-042024-08-030001835632mrvl:DataCenterMember2023-01-292023-07-290001835632us-gaap:ProductConcentrationRiskMembermrvl:DataCenterMemberus-gaap:SalesRevenueNetMember2023-01-292023-07-290001835632mrvl:EnterpriseNetworkingMember2024-05-052024-08-030001835632us-gaap:ProductConcentrationRiskMembermrvl:EnterpriseNetworkingMemberus-gaap:SalesRevenueNetMember2024-05-052024-08-030001835632mrvl:EnterpriseNetworkingMember2023-04-302023-07-290001835632us-gaap:ProductConcentrationRiskMembermrvl:EnterpriseNetworkingMemberus-gaap:SalesRevenueNetMember2023-04-302023-07-290001835632mrvl:EnterpriseNetworkingMember2024-02-042024-08-030001835632us-gaap:ProductConcentrationRiskMembermrvl:EnterpriseNetworkingMemberus-gaap:SalesRevenueNetMember2024-02-042024-08-030001835632mrvl:EnterpriseNetworkingMember2023-01-292023-07-290001835632us-gaap:ProductConcentrationRiskMembermrvl:EnterpriseNetworkingMemberus-gaap:SalesRevenueNetMember2023-01-292023-07-290001835632mrvl:CarrierInfrastructureMember2024-05-052024-08-030001835632us-gaap:ProductConcentrationRiskMembermrvl:CarrierInfrastructureMemberus-gaap:SalesRevenueNetMember2024-05-052024-08-030001835632mrvl:CarrierInfrastructureMember2023-04-302023-07-290001835632us-gaap:ProductConcentrationRiskMembermrvl:CarrierInfrastructureMemberus-gaap:SalesRevenueNetMember2023-04-302023-07-290001835632mrvl:CarrierInfrastructureMember2024-02-042024-08-030001835632us-gaap:ProductConcentrationRiskMembermrvl:CarrierInfrastructureMemberus-gaap:SalesRevenueNetMember2024-02-042024-08-030001835632mrvl:CarrierInfrastructureMember2023-01-292023-07-290001835632us-gaap:ProductConcentrationRiskMembermrvl:CarrierInfrastructureMemberus-gaap:SalesRevenueNetMember2023-01-292023-07-290001835632mrvl:ConsumerMember2024-05-052024-08-030001835632us-gaap:ProductConcentrationRiskMembermrvl:ConsumerMemberus-gaap:SalesRevenueNetMember2024-05-052024-08-030001835632mrvl:ConsumerMember2023-04-302023-07-290001835632us-gaap:ProductConcentrationRiskMembermrvl:ConsumerMemberus-gaap:SalesRevenueNetMember2023-04-302023-07-290001835632mrvl:ConsumerMember2024-02-042024-08-030001835632us-gaap:ProductConcentrationRiskMembermrvl:ConsumerMemberus-gaap:SalesRevenueNetMember2024-02-042024-08-030001835632mrvl:ConsumerMember2023-01-292023-07-290001835632us-gaap:ProductConcentrationRiskMembermrvl:ConsumerMemberus-gaap:SalesRevenueNetMember2023-01-292023-07-290001835632mrvl:AutomotiveAndIndustrialMember2024-05-052024-08-030001835632us-gaap:ProductConcentrationRiskMembermrvl:AutomotiveAndIndustrialMemberus-gaap:SalesRevenueNetMember2024-05-052024-08-030001835632mrvl:AutomotiveAndIndustrialMember2023-04-302023-07-290001835632us-gaap:ProductConcentrationRiskMembermrvl:AutomotiveAndIndustrialMemberus-gaap:SalesRevenueNetMember2023-04-302023-07-290001835632mrvl:AutomotiveAndIndustrialMember2024-02-042024-08-030001835632us-gaap:ProductConcentrationRiskMembermrvl:AutomotiveAndIndustrialMemberus-gaap:SalesRevenueNetMember2024-02-042024-08-030001835632mrvl:AutomotiveAndIndustrialMember2023-01-292023-07-290001835632us-gaap:ProductConcentrationRiskMembermrvl:AutomotiveAndIndustrialMemberus-gaap:SalesRevenueNetMember2023-01-292023-07-290001835632country:CN2024-05-052024-08-030001835632country:CNus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-05-052024-08-030001835632country:CN2023-04-302023-07-290001835632country:CNus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-302023-07-290001835632country:CN2024-02-042024-08-030001835632country:CNus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-02-042024-08-030001835632country:CN2023-01-292023-07-290001835632country:CNus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-292023-07-290001835632country:US2024-05-052024-08-030001835632country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-05-052024-08-030001835632country:US2023-04-302023-07-290001835632country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-302023-07-290001835632country:US2024-02-042024-08-030001835632country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-02-042024-08-030001835632country:US2023-01-292023-07-290001835632country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-292023-07-290001835632country:SG2024-05-052024-08-030001835632country:SGus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-05-052024-08-030001835632country:SG2023-04-302023-07-290001835632country:SGus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-302023-07-290001835632country:SG2024-02-042024-08-030001835632country:SGus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-02-042024-08-030001835632country:SG2023-01-292023-07-290001835632country:SGus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-292023-07-290001835632country:TH2024-05-052024-08-030001835632country:THus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-05-052024-08-030001835632country:TH2023-04-302023-07-290001835632country:THus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-302023-07-290001835632country:TH2024-02-042024-08-030001835632country:THus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-02-042024-08-030001835632country:TH2023-01-292023-07-290001835632country:THus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-292023-07-290001835632country:MY2024-05-052024-08-030001835632country:MYus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-05-052024-08-030001835632country:MY2023-04-302023-07-290001835632country:MYus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-302023-07-290001835632country:MY2024-02-042024-08-030001835632country:MYus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-02-042024-08-030001835632country:MY2023-01-292023-07-290001835632country:MYus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-292023-07-290001835632country:TW2024-05-052024-08-030001835632country:TWus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-05-052024-08-030001835632country:TW2023-04-302023-07-290001835632country:TWus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-302023-07-290001835632country:TW2024-02-042024-08-030001835632country:TWus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-02-042024-08-030001835632country:TW2023-01-292023-07-290001835632country:TWus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-292023-07-290001835632country:JP2024-05-052024-08-030001835632country:JPus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-05-052024-08-030001835632country:JP2023-04-302023-07-290001835632country:JPus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-302023-07-290001835632country:JP2024-02-042024-08-030001835632country:JPus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-02-042024-08-030001835632country:JP2023-01-292023-07-290001835632country:JPus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-292023-07-290001835632country:PH2024-05-052024-08-030001835632country:PHus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-05-052024-08-030001835632country:PH2023-04-302023-07-290001835632country:PHus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-302023-07-290001835632country:PH2024-02-042024-08-030001835632country:PHus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-02-042024-08-030001835632country:PH2023-01-292023-07-290001835632country:PHus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-292023-07-290001835632country:FI2024-05-052024-08-030001835632country:FIus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-05-052024-08-030001835632country:FI2023-04-302023-07-290001835632country:FIus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-302023-07-290001835632country:FI2024-02-042024-08-030001835632country:FIus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-02-042024-08-030001835632country:FI2023-01-292023-07-290001835632country:FIus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-292023-07-290001835632mrvl:OtherCountriesMember2024-05-052024-08-030001835632mrvl:OtherCountriesMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-05-052024-08-030001835632mrvl:OtherCountriesMember2023-04-302023-07-290001835632mrvl:OtherCountriesMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-302023-07-290001835632mrvl:OtherCountriesMember2024-02-042024-08-030001835632mrvl:OtherCountriesMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-02-042024-08-030001835632mrvl:OtherCountriesMember2023-01-292023-07-290001835632mrvl:OtherCountriesMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-292023-07-290001835632us-gaap:SalesChannelDirectlyToConsumerMember2024-05-052024-08-030001835632us-gaap:SalesChannelDirectlyToConsumerMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-05-052024-08-030001835632us-gaap:SalesChannelDirectlyToConsumerMember2023-04-302023-07-290001835632us-gaap:SalesChannelDirectlyToConsumerMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-302023-07-290001835632us-gaap:SalesChannelDirectlyToConsumerMember2024-02-042024-08-030001835632us-gaap:SalesChannelDirectlyToConsumerMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-02-042024-08-030001835632us-gaap:SalesChannelDirectlyToConsumerMember2023-01-292023-07-290001835632us-gaap:SalesChannelDirectlyToConsumerMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-292023-07-290001835632us-gaap:SalesChannelThroughIntermediaryMember2024-05-052024-08-030001835632us-gaap:SalesChannelThroughIntermediaryMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-05-052024-08-030001835632us-gaap:SalesChannelThroughIntermediaryMember2023-04-302023-07-290001835632us-gaap:SalesChannelThroughIntermediaryMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-302023-07-290001835632us-gaap:SalesChannelThroughIntermediaryMember2024-02-042024-08-030001835632us-gaap:SalesChannelThroughIntermediaryMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-02-042024-08-030001835632us-gaap:SalesChannelThroughIntermediaryMember2023-01-292023-07-290001835632us-gaap:SalesChannelThroughIntermediaryMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-292023-07-290001835632mrvl:FiveYearTrancheLoanMembermrvl:TermLoanMember2024-08-030001835632mrvl:FiveYearTrancheLoanMembermrvl:TermLoanMember2024-02-030001835632mrvl:TermLoanMember2024-08-030001835632mrvl:TermLoanMember2024-02-030001835632mrvl:MTGAndMTISeniorNotesDueIn2028Memberus-gaap:SeniorNotesMember2024-08-030001835632mrvl:MTGAndMTISeniorNotesDueIn2028Memberus-gaap:SeniorNotesMember2024-02-030001835632mrvl:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2024-08-030001835632mrvl:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2024-02-030001835632mrvl:SeniorNotesDue2028Memberus-gaap:SeniorNotesMember2024-08-030001835632mrvl:SeniorNotesDue2028Memberus-gaap:SeniorNotesMember2024-02-030001835632mrvl:SeniorNotesDue2029Memberus-gaap:SeniorNotesMember2024-08-030001835632mrvl:SeniorNotesDue2029Memberus-gaap:SeniorNotesMember2024-02-030001835632mrvl:SeniorNotesDue2031Memberus-gaap:SeniorNotesMember2024-08-030001835632mrvl:SeniorNotesDue2031Memberus-gaap:SeniorNotesMember2024-02-030001835632mrvl:SeniorNotesDue2033Memberus-gaap:SeniorNotesMember2024-08-030001835632mrvl:SeniorNotesDue2033Memberus-gaap:SeniorNotesMember2024-02-030001835632us-gaap:SeniorNotesMember2024-08-030001835632us-gaap:SeniorNotesMember2024-02-030001835632mrvl:FiveYearTrancheLoanMembermrvl:TermLoanMember2024-02-042024-08-030001835632mrvl:TermLoanMember2020-12-070001835632mrvl:ThreeYearTrancheLoanMembermrvl:TermLoanMember2020-12-070001835632mrvl:ThreeYearTrancheLoanMembermrvl:TermLoanMember2020-12-072020-12-070001835632mrvl:FiveYearTrancheLoanMembermrvl:TermLoanMember2020-12-070001835632mrvl:FiveYearTrancheLoanMembermrvl:TermLoanMember2020-12-072020-12-070001835632mrvl:ThreeYearTrancheLoanMembermrvl:TermLoanMember2023-07-302023-10-280001835632mrvl:FiveYearTrancheLoanMembermrvl:TermLoanMemberus-gaap:DebtInstrumentRedemptionPeriodOneMember2024-02-042024-08-030001835632mrvl:FiveYearTrancheLoanMembermrvl:TermLoanMemberus-gaap:DebtInstrumentRedemptionPeriodTwoMember2024-02-042024-08-030001835632mrvl:FiveYearTrancheLoanMembermrvl:TermLoanMemberus-gaap:DebtInstrumentRedemptionPeriodThreeMember2024-02-042024-08-030001835632mrvl:FiveYearTrancheLoanMembermrvl:TermLoanMember2024-05-052024-08-030001835632mrvl:RevolvingCreditFacility2020Memberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2020-12-070001835632mrvl:A2023RevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2023-04-140001835632mrvl:A2023RevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2023-04-142023-04-140001835632mrvl:A2023RevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-02-042024-08-030001835632mrvl:SeniorNotesDue2029Memberus-gaap:SeniorNotesMember2023-09-180001835632mrvl:SeniorNotesDue2033Memberus-gaap:SeniorNotesMember2023-09-180001835632mrvl:SeniorNotesDue2029Memberus-gaap:SeniorNotesMember2023-09-182023-09-180001835632mrvl:SeniorNotesDue2033Memberus-gaap:SeniorNotesMember2023-09-182023-09-180001835632mrvl:SeniorNotesDue2029And2033Memberus-gaap:SeniorNotesMember2023-09-182023-09-180001835632mrvl:SeniorNotesDue2029And2033Memberus-gaap:SeniorNotesMember2024-08-030001835632mrvl:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2021-04-120001835632mrvl:SeniorNotesDue2028Memberus-gaap:SeniorNotesMember2021-04-120001835632mrvl:SeniorNotesDue2031Memberus-gaap:SeniorNotesMember2021-04-120001835632mrvl:SeniorNotesDue2026Memberus-gaap:SeniorNotesMember2021-04-122021-04-120001835632mrvl:SeniorNotesDue2028Memberus-gaap:SeniorNotesMember2021-04-122021-04-120001835632mrvl:SeniorNotesDue2031Memberus-gaap:SeniorNotesMember2021-04-122021-04-120001835632us-gaap:SeniorNotesMember2021-04-122021-04-120001835632mrvl:MTGSeniorNotesDue2023Memberus-gaap:SeniorNotesMember2018-06-220001835632mrvl:MTGSeniorNotesDue2028Memberus-gaap:SeniorNotesMember2018-06-220001835632mrvl:MTGSeniorNotesMemberus-gaap:SeniorNotesMember2021-04-300001835632mrvl:MTISeniorNotesDue2023Memberus-gaap:SeniorNotesMember2021-04-300001835632mrvl:MTGSeniorNotesDue2028Memberus-gaap:SeniorNotesMember2021-04-300001835632mrvl:MTGSeniorNotesDue2023Memberus-gaap:SeniorNotesMember2021-05-042021-05-040001835632mrvl:MTGSeniorNotesDue2028Memberus-gaap:SeniorNotesMember2021-05-042021-05-040001835632mrvl:MTIAndMTG2023NotesMemberus-gaap:SeniorNotesMember2023-06-222023-06-220001835632mrvl:MTISeniorNotesDue2028Memberus-gaap:SeniorNotesMember2021-04-300001835632mrvl:MTISeniorNotesMemberus-gaap:SeniorNotesMember2021-04-012021-04-300001835632mrvl:MTGAndMTI2028SeniorNotesMemberus-gaap:SeniorNotesMember2024-08-030001835632mrvl:PurchaseCommitmentsToFoundriesAndTestAndAssemblyPartnersMember2024-08-030001835632mrvl:TechnologyLicenseAgreementMember2024-08-030001835632srt:MinimumMembermrvl:WafersSubstratesAndOtherManufacturingProductsMember2024-02-042024-08-030001835632srt:MaximumMembermrvl:WafersSubstratesAndOtherManufacturingProductsMember2024-02-042024-08-030001835632mrvl:WafersSubstratesAndOtherManufacturingProductsMember2024-02-042024-08-030001835632mrvl:WafersSubstratesAndOtherManufacturingProductsMember2024-08-030001835632mrvl:TechnologyLicenseAgreementMember2021-09-012021-09-300001835632mrvl:TechnologyLicenseAgreementMember2021-09-300001835632us-gaap:DevelopedTechnologyRightsMember2024-08-030001835632us-gaap:DevelopedTechnologyRightsMember2024-02-042024-08-030001835632mrvl:CustomerContractsAndRelationshipsMember2024-08-030001835632mrvl:CustomerContractsAndRelationshipsMember2024-02-042024-08-030001835632us-gaap:TradeNamesMember2024-08-030001835632us-gaap:TradeNamesMember2024-02-042024-08-030001835632us-gaap:InProcessResearchAndDevelopmentMember2024-08-030001835632us-gaap:DevelopedTechnologyRightsMember2024-02-030001835632us-gaap:DevelopedTechnologyRightsMember2023-01-292024-02-030001835632mrvl:CustomerContractsAndRelationshipsMember2024-02-030001835632mrvl:CustomerContractsAndRelationshipsMember2023-01-292024-02-030001835632us-gaap:TradeNamesMember2024-02-030001835632us-gaap:TradeNamesMember2023-01-292024-02-0300018356322023-01-292024-02-030001835632us-gaap:InProcessResearchAndDevelopmentMember2024-02-030001835632us-gaap:InProcessResearchAndDevelopmentMembersrt:MinimumMember2024-02-042024-08-030001835632us-gaap:InProcessResearchAndDevelopmentMembersrt:MaximumMember2024-02-042024-08-030001835632us-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel1Member2024-08-030001835632us-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel2Member2024-08-030001835632us-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel3Member2024-08-030001835632us-gaap:BankTimeDepositsMember2024-08-030001835632us-gaap:FairValueInputsLevel1Member2024-08-030001835632us-gaap:FairValueInputsLevel2Member2024-08-030001835632us-gaap:FairValueInputsLevel3Member2024-08-030001835632us-gaap:FairValueInputsLevel1Memberus-gaap:ForwardContractsMember2024-08-030001835632us-gaap:FairValueInputsLevel2Memberus-gaap:ForwardContractsMember2024-08-030001835632us-gaap:FairValueInputsLevel3Memberus-gaap:ForwardContractsMember2024-08-030001835632us-gaap:ForwardContractsMember2024-08-030001835632us-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel1Member2024-02-030001835632us-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel2Member2024-02-030001835632us-gaap:BankTimeDepositsMemberus-gaap:FairValueInputsLevel3Member2024-02-030001835632us-gaap:BankTimeDepositsMember2024-02-030001835632us-gaap:FairValueInputsLevel1Member2024-02-030001835632us-gaap:FairValueInputsLevel2Member2024-02-030001835632us-gaap:FairValueInputsLevel3Member2024-02-030001835632us-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMember2024-08-030001835632us-gaap:FairValueInputsLevel2Memberus-gaap:SeniorNotesMember2024-02-030001835632mrvl:Fiscal2024PlanMember2024-05-052024-08-030001835632mrvl:Fiscal2024PlanMember2024-02-042024-08-030001835632mrvl:Fiscal2024PlanMember2023-04-302023-07-290001835632mrvl:Fiscal2024PlanMember2023-01-292023-07-290001835632us-gaap:IntellectualPropertyMembermrvl:ServerProcessorProductsMember2024-05-052024-08-030001835632us-gaap:IntellectualPropertyMembermrvl:ServerProcessorProductsMember2023-04-302023-07-290001835632us-gaap:IntellectualPropertyMembermrvl:ServerProcessorProductsMember2024-02-042024-08-030001835632us-gaap:IntellectualPropertyMembermrvl:ServerProcessorProductsMember2023-01-292023-07-290001835632us-gaap:StockCompensationPlanMember2024-05-052024-08-030001835632us-gaap:StockCompensationPlanMember2023-04-302023-07-290001835632us-gaap:StockCompensationPlanMember2024-02-042024-08-030001835632us-gaap:StockCompensationPlanMember2023-01-292023-07-290001835632us-gaap:MachineryAndEquipmentMember2024-08-030001835632us-gaap:MachineryAndEquipmentMember2024-02-030001835632us-gaap:LandBuildingsAndImprovementsMember2024-08-030001835632us-gaap:LandBuildingsAndImprovementsMember2024-02-030001835632us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2024-08-030001835632us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2024-02-030001835632us-gaap:FurnitureAndFixturesMember2024-08-030001835632us-gaap:FurnitureAndFixturesMember2024-02-030001835632us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-02-030001835632us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-02-042024-08-030001835632us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2024-08-030001835632us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-280001835632us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-01-292023-07-290001835632us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-07-2900018356322016-11-1700018356322016-11-1600018356322018-10-1600018356322024-03-070001835632mrvl:MatthewJ.MurphyJune2024Plan1Membermrvl:MatthewJ.MurphyMember2024-05-052024-08-030001835632mrvl:MatthewJ.MurphyJune2024Plan1Membermrvl:MatthewJ.MurphyMember2024-08-030001835632mrvl:MatthewJ.MurphyJune2024PlanMembermrvl:MatthewJ.MurphyMember2024-05-052024-08-030001835632mrvl:MatthewJ.MurphyJune2024PlanMembermrvl:MatthewJ.MurphyMember2024-08-030001835632mrvl:ChristopherKoopmansMember2024-05-052024-08-030001835632mrvl:ChristopherKoopmansMember2024-08-03

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended August 3, 2024
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             
Commission file number: 001-40357
marvell_logo.jpg
MARVELL TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
Delaware 85-3971597
(State or other jurisdiction of
incorporation or organization)
 (I.R.S. Employer
Identification No.)
1000 N. West Street, Suite 1200
Wilmington, Delaware 19801
(302) 295-4840
(Address of principal executive offices, zip code and registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
 
     
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.002 per share MRVL The Nasdaq Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.      Yes      No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).      Yes      No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filer
Non-accelerated filer
¨  
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes     No
The number of shares of common stock of the registrant outstanding as of August 23, 2024 was 866.2 million.


TABLE OF CONTENTS
 
  Page
Item 1.
Item 2.
Item 3.
Item 4.
Item 1.
Item 1A.
Item 2.
Item 5.
Item 6.
1

PART I: FINANCIAL INFORMATION

Item 1. Financial Statements
MARVELL TECHNOLOGY, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(In millions, except par value per share)
 
August 3,
2024
February 3,
2024
ASSETS
Current assets:
Cash and cash equivalents$808.7 $950.8 
Accounts receivable, net1,060.1 1,121.6 
Inventories817.8 864.4 
Prepaid expenses and other current assets77.3 125.9 
Total current assets2,763.9 3,062.7 
Property and equipment, net781.5 756.0 
Goodwill11,586.9 11,586.9 
Acquired intangible assets, net3,463.4 4,004.1 
Deferred tax assets347.5 311.9 
Other non-current assets1,350.2 1,506.9 
Total assets$20,293.4 $21,228.5 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$453.4 $411.3 
Accrued liabilities763.8 1,032.9 
Accrued employee compensation200.0 262.7 
Short-term debt129.3 107.3 
Total current liabilities1,546.5 1,814.2 
Long-term debt3,996.5 4,058.6 
Other non-current liabilities545.5 524.3 
Total liabilities6,088.5 6,397.1 
Commitments and contingencies (Note 5)
Stockholders’ equity:
Common stock, $0.002 par value
1.7 1.7 
Additional paid-in capital14,732.9 14,845.3 
Accumulated other comprehensive income (loss)(0.4)1.1 
Accumulated deficit(529.3)(16.7)
Total stockholders’ equity14,204.9 14,831.4 
Total liabilities and stockholders’ equity$20,293.4 $21,228.5 

See accompanying notes to unaudited condensed consolidated financial statements
2

MARVELL TECHNOLOGY, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions, except per share amounts)
 
 Three Months EndedSix Months Ended
 August 3,
2024
July 29,
2023
August 3,
2024
July 29,
2023
Net revenue$1,272.9 $1,340.9 $2,433.8 $2,662.6 
Cost of goods sold685.3 819.8 1,318.4 1,584.3 
Gross profit587.6 521.1 1,115.4 1,078.3 
Operating expenses:
Research and development486.7 474.8 962.8 955.5 
Selling, general and administrative197.3 210.0 397.2 409.0 
Restructuring related charges4.0 42.0 8.1 101.9 
Total operating expenses688.0 726.8 1,368.1 1,466.4 
Operating loss(100.4)(205.7)(252.7)(388.1)
Interest expense(48.4)(53.8)(97.2)(106.5)
Interest income and other, net2.6 7.9 5.9 10.7 
Interest and other loss, net(45.8)(45.9)(91.3)(95.8)
Loss before income taxes(146.2)(251.6)(344.0)(483.9)
Provision (benefit) for income taxes47.1 (44.1)64.9 (107.5)
Net loss$(193.3)$(207.5)$(408.9)$(376.4)
Net loss per share — basic$(0.22)$(0.24)$(0.47)$(0.44)
Net loss per share — diluted$(0.22)$(0.24)$(0.47)$(0.44)
Weighted-average shares:
Basic865.7 860.9 865.4 858.8 
Diluted865.7 860.9 865.4 858.8 
See accompanying notes to unaudited condensed consolidated financial statements
3

MARVELL TECHNOLOGY, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(In millions)
 
 Three Months EndedSix Months Ended
August 3,
2024
July 29,
2023
August 3,
2024
July 29,
2023
Net loss$(193.3)$(207.5)$(408.9)$(376.4)
Other comprehensive loss, net of tax
Net change in unrealized loss on cash flow hedges(0.8)(0.1)(1.5)(1.0)
Other comprehensive loss, net of tax(0.8)(0.1)(1.5)(1.0)
Comprehensive loss, net of tax$(194.1)$(207.6)$(410.4)$(377.4)

See accompanying notes to unaudited condensed consolidated financial statements
4

MARVELL TECHNOLOGY, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(In millions, except per share amounts)

Common StockAdditional Paid-in CapitalAccumulated Other Comprehensive Income (Loss)Accumulated Deficit
SharesAmountTotal
Balance at February 3, 2024865.5 $1.7 $14,845.3 $1.1 $(16.7)$14,831.4 
Issuance of common stock in connection with equity incentive plans2.2 — 2.2 — — 2.2 
Tax withholdings related to net share settlement of restricted stock units— — (74.1)— — (74.1)
Stock-based compensation— — 137.3 — — 137.3 
Repurchase of common stock(2.2)— (150.0)— — (150.0)
Cash dividends declared and paid ($0.06 per share)
— — — — (51.8)(51.8)
Net loss— — — — (215.6)(215.6)
Other comprehensive loss— — — (0.7)— (0.7)
Balance at May 4, 2024865.5 $1.7 $14,760.7 $0.4 $(284.1)$14,478.7 
Issuance of common stock in connection with equity incentive plans3.2 — 49.3 — — 49.3 
Tax withholdings related to net share settlement of restricted stock units— — (57.6)— — (57.6)
Stock-based compensation— — 155.5 — — 155.5 
Repurchase of common stock(2.5)— (175.0)— — (175.0)
Cash dividends declared and paid ($0.06 per share)
— — — — (51.9)(51.9)
Net loss— — — — (193.3)(193.3)
Other comprehensive loss— — — (0.8)— (0.8)
Balance at August 3, 2024866.2 $1.7 $14,732.9 $(0.4)$(529.3)$14,204.9 

Common StockAdditional Paid-in CapitalAccumulated Other Comprehensive LossRetained Earnings
SharesAmountTotal
Balance at January 28, 2023856.1 $1.7 $14,512.0 $ $1,123.5 $15,637.2 
Issuance of common stock in connection with equity incentive plans3.8 — 8.3 — — 8.3 
Tax withholdings related to net share settlement of restricted stock units— — (72.6)— — (72.6)
Stock-based compensation— — 142.2 — — 142.2 
Cash dividends declared and paid ($0.06 per share)
— — — — (51.4)(51.4)
Net loss— — — — (168.9)(168.9)
Other comprehensive loss— — — (0.9)— (0.9)
Balance at April 29, 2023859.9 $1.7 $14,589.9 $(0.9)$903.2 $15,493.9 
Issuance of common stock in connection with equity incentive plans3.4 — 52.1 — — 52.1 
Tax withholdings related to net share settlement of restricted stock units— — (51.2)— — (51.2)
Stock-based compensation— — 154.0 — — 154.0 
Cash dividends declared and paid ($0.06 per share)
— — — — (51.7)(51.7)
Net loss— — — — (207.5)(207.5)
Other comprehensive loss— — — (0.1)— (0.1)
Balance at July 29, 2023863.3 $1.7 $14,744.8 $(1.0)$644.0 $15,389.5 

See accompanying notes to unaudited condensed consolidated financial statements
5

MARVELL TECHNOLOGY, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
 Six Months Ended
 August 3,
2024
July 29,
2023
Cash flows from operating activities:
Net loss$(408.9)$(376.4)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization148.9 153.9 
Stock-based compensation291.4 296.0 
Amortization of acquired intangible assets540.6 541.8 
Restructuring related impairment charges 2.3 31.4 
Deferred income taxes(58.3)(226.7)
Other expense, net33.1 21.7 
Changes in assets and liabilities:
Accounts receivable61.5 (16.9)
Prepaid expenses and other assets221.7 (39.3)
Inventories48.0 52.5 
Accounts payable34.8 (86.8)
Accrued employee compensation(59.2)(59.0)
Accrued liabilities and other non-current liabilities (225.0)28.7 
Net cash provided by operating activities630.9 320.9 
Cash flows from investing activities:
Purchases of technology licenses(5.7)(3.0)
Purchases of property and equipment(139.7)(210.9)
Acquisitions, net of cash acquired(10.4)(5.5)
Other, net0.9 (0.3)
Net cash used in investing activities(154.9)(219.7)
Cash flows from financing activities:
Repurchases of common stock(325.0) 
Proceeds from employee stock plans51.6 60.4 
Tax withholding paid on behalf of employees for net share settlement(131.7)(123.8)
Dividend payments to stockholders(103.7)(103.1)
Payments on technology license obligations(65.5)(78.6)
Proceeds from borrowings 250.0 
Principal payments of debt(43.8)(593.7)
Net cash used in financing activities(618.1)(588.8)
Net decrease in cash and cash equivalents(142.1)(487.6)
Cash and cash equivalents at beginning of period950.8 911.0 
Cash and cash equivalents at end of period$808.7 $423.4 

See accompanying notes to unaudited condensed consolidated financial statements
6

MARVELL TECHNOLOGY, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS



Note 1. Basis of Presentation

The unaudited condensed consolidated financial statements of Marvell Technology, Inc. (“MTI”), a Delaware corporation, and its wholly owned subsidiaries (the “Company”), as of and for the three and six months ended August 3, 2024, have been prepared as required by the U.S. Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) have been condensed or omitted as permitted by the SEC. These unaudited condensed consolidated financial statements and related notes should be read in conjunction with the Company’s fiscal 2024 audited financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 3, 2024. In the opinion of management, the financial statements include all adjustments, including normal recurring adjustments and other adjustments, that are considered necessary for fair presentation of the Company’s financial position and results of operations. All inter-company accounts and transactions have been eliminated. Operating results for the periods presented herein are not necessarily indicative of the results that may be expected for the entire year. Certain prior period amounts have been reclassified to conform to current period presentation. These financial statements should also be read in conjunction with the Company’s critical accounting policies included in the Company’s Annual Report on Form 10-K for the fiscal year ended February 3, 2024 and those included in this Quarterly Report on Form 10-Q below. All dollar amounts in the financial statements and tables in these notes, except per share amounts, are stated in millions of U.S. dollars unless otherwise noted.

The Company’s fiscal year is the 52- or 53-week period ending on the Saturday closest to January 31. Accordingly, every fifth or sixth fiscal year will have a 53-week period. The additional week in a 53-week year is added to the fourth quarter, making such quarter consist of 14 weeks. Fiscal 2024 had a 53-week year. Fiscal 2025 is a 52-week year.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, including those related to revenue recognition, provisions for sales returns and allowances, inventory excess and obsolescence, goodwill and other intangible assets, restructuring, income taxes, litigation and other contingencies. Actual results could differ from these estimates and such differences could affect the results of operations reported in future periods. In the current macroeconomic environment, these estimates could require increased judgment and carry a higher degree of variability and volatility. As events continue to evolve and additional information becomes available, these estimates may change materially in future periods.

Note 2. Recent Accounting Pronouncements

Accounting Pronouncements Not Yet Effective

In November 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280) to improve reportable segment disclosures. The update requires disclosure of incremental segment information on an annual and interim basis. The ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective application to all prior periods presented in the financial statements. Early adoption is permitted. The Company is evaluating the impact that this new standard will have on the Company’s consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) to improve income tax disclosures to enhance transparency and decision usefulness of income tax disclosure. The ASU is effective for fiscal years beginning after December 15, 2024 with updates to be applied on a prospective basis with the option to apply the standard retrospectively. Early adoption is permitted. The Company is evaluating the impact that this new standard will have on the Company’s consolidated financial statements.
7

MARVELL TECHNOLOGY, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ‑ (Continued)

Note 3. Revenue

Disaggregation of Revenue

The majority of the Company’s revenue is generated from sales of the Company’s products.

The following table summarizes net revenue disaggregated by end market (in millions, except percentages):

Three Months EndedSix Months Ended
August 3,
2024
% of TotalJuly 29,
2023
% of TotalAugust 3,
2024
% of TotalJuly 29,
2023
% of Total
Net revenue by end market:
Data center$880.9 69 %$459.8 34 %$1,697.3 70 %$895.6 34 %
Enterprise networking151.0 12 %327.7 24 %304.1 13 %692.3 26 %
Carrier infrastructure75.9 6 %275.5 21 %147.7 6 %565.4 21 %
Consumer88.9 7 %167.7 13 %130.9 5 %309.8 12 %
Automotive/industrial76.2 6 %110.2 8 %153.8 6 %199.5 7 %
$1,272.9 $1,340.9 $2,433.8 $2,662.6 

The following table summarizes net revenue disaggregated by primary geographical market based on destination of shipment (in millions, except percentages):

Three Months EndedSix Months Ended
August 3,
2024
% of TotalJuly 29,
2023
% of TotalAugust 3,
2024
% of TotalJuly 29,
2023
% of Total
Net revenue based on destination of shipment:
China$586.8 46 %$569.3 42 %$1,116.4 46 %$1,085.041 %
United States202.9 16 %202.8 15 %419.4 17 %390.115 %
Singapore142.2 11 %70.9 5 %253.5 10 %183.2 7 %
Thailand95.0 7 %76.0 6 %160.0 7 %121.4 5 %
Malaysia29.4 2 %39.5 3 %82.4 3 %138.0 5 %
Taiwan38.5 3 %59.1 4 %81.1 3 %112.9 4 %
Japan33.2 3 %44.0 3 %50.5 2 %87.83 %
Philippines34.1 3 %22.0 2 %47.2 2 %33.61 %
Finland19.6 2 %115.3 9 %42.0 2 %195.4 7 %
Other91.2 7 %142.0 11 %181.3 8 %315.212 %
$1,272.9 $1,340.9 $2,433.8 $2,662.6

These destinations of shipment are not necessarily indicative of the geographic location of the Company’s end customers or the country in which the Company’s end customers sell devices containing the Company’s products. For example, a substantial majority of the shipments made to China relate to sales to non-China based customers that have factories or contract manufacturing operations located within China.

8

MARVELL TECHNOLOGY, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ‑ (Continued)

The following table summarizes net revenue disaggregated by customer type (in millions, except percentages):

Three Months EndedSix Months Ended
August 3,
2024
% of TotalJuly 29,
2023
% of TotalAugust 3,
2024
% of TotalJuly 29,
2023
% of Total
Net revenue by customer type:
Direct customers$725.7 57 %$857.3 64 %$1,333.8 55 %$1,748.1 66 %
Distributors547.2 43 %483.6 36 %1,100.0 45 %914.5 34 %
$1,272.9 $1,340.9 $2,433.8 $2,662.6 

Contract Liabilities

Contract liabilities consist of the Company’s obligation to transfer goods or services to a customer for which the Company has received consideration or the amount is due from the customer. Contract liability balances are comprised of deferred revenue. The amount of revenue recognized during the six months ended August 3, 2024 that was included in the deferred revenue balance at February 3, 2024 was not material.

As of the end of a reporting period, some of the performance obligations associated with contracts will have been unsatisfied or only partially satisfied. In accordance with the practical expedients available in the guidance, the Company does not disclose the value of unsatisfied performance obligations for contracts with an original expected duration of one year or less.

Note 4. Debt

Summary of Borrowings and Outstanding Debt

The following table summarizes the Company’s outstanding debt at August 3, 2024 and February 3, 2024 (in millions):

August 3,
2024
February 3,
2024
Face Value Outstanding:
2026 Term Loan - 5-Year Tranche$656.2 $700.0 
     Term Loan Total656.2 700.0 
4.875% MTG/MTI 2028 Senior Notes
499.9 499.9 
1.650% 2026 Senior Notes
500.0 500.0 
2.450% 2028 Senior Notes
750.0 750.0 
5.750% 2029 Senior Notes
500.0 500.0 
2.950% 2031 Senior Notes
750.0 750.0 
5.950% 2033 Senior Notes
500.0 500.0 
     Senior Notes Total3,499.9 3,499.9 
Total borrowings$4,156.1 $4,199.9 
Less: Unamortized debt discount and issuance cost(30.3)(34.0)
Net carrying amount of debt$4,125.8 $4,165.9 
Less: Current portion (1)129.3 107.3 
Non-current portion$3,996.5 $4,058.6 

(1)As of August 3, 2024, the current portion of outstanding debt that is due within twelve months includes a portion of the 2026 Term Loan - 5-Year Tranche. The weighted-average interest rate on short-term debt outstanding at August 3, 2024 and February 3, 2024 was 6.793% and 6.830%, respectively.

9

MARVELL TECHNOLOGY, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ‑ (Continued)

2024 and 2026 Term Loans

On December 7, 2020, the Company entered into a term loan credit agreement with a lending syndicate led by JP Morgan Chase Bank, N.A (the “2024 and 2026 Term Loan Agreement”) in order to finance the acquisition of Inphi Corporation (“Inphi”). The 2024 and 2026 Term Loan Agreement provides for borrowings of $1.8 billion consisting of: (i) $875.0 million loan with a 3-year term from the funding date (the “3-Year Tranche Loan”) and (ii) $875.0 million loan with a 5-year term from the funding date (the “5-Year Tranche Loan” and, together with the 3-Year Tranche Loan, the “2024 and 2026 Term Loans”).

On April 14, 2023, the Company entered into an amendment to the 2024 and 2026 Term Loan Agreement. The amendment modifies the existing agreement to, among other things, adopt Secured Overnight Financing Rate (“SOFR”) interest rates and conform the maximum leverage ratio financial covenant with the amended and restated revolving credit agreement.

The 3-Year Tranche Loan, due on April 19, 2024, which had a remaining principal of $735.0 million, was repaid in full during the quarter ended October 28, 2023.

Pursuant to the amended 2024 and 2026 Term Loan Agreement, the 5-Year Tranche Loan has a stated floating interest rate which equates to adjusted term SOFR + 137.5 bps. The effective interest rate for the 5-Year Tranche Loan was 5.113% as of August 3, 2024. The 5-Year Tranche Loan requires scheduled principal payments at the end of each fiscal quarter equal to (i) 1.25% of the aggregate principal amount on the term funding date for the first four full fiscal quarters following the term loan funding date, (ii) 2.50% of the aggregate principal amount on the term funding date for the fifth through twelfth full fiscal quarters following the term loan funding date, and (iii) 3.75% of the aggregate principal amount on the term funding date for each fiscal quarter following the twelfth full fiscal quarter following the term loan funding date. During the three and six months ended August 3, 2024, the Company repaid $21.9 million and $43.8 million, respectively, of the principal outstanding of the 5-Year Tranche Loan. As of August 3, 2024, the Company has $656.2 million of 5-Year Tranche Loan borrowings outstanding.

The 2024 and 2026 Term Loan Agreement requires that the Company and its subsidiaries comply with covenants relating to customary matters, including with respect to creating or permitting certain liens, entering into sale and leaseback transactions, and consolidating, merging, liquidating or dissolving. It also prohibits subsidiaries of the Company from incurring additional indebtedness, subject to certain exceptions, and requires that the Company maintain a leverage ratio financial covenant as of the end of any fiscal quarter.

2023 Revolving Credit Facility

On December 7, 2020, the Company entered into a revolving line of credit agreement with a lending syndicate led by JP Morgan Chase Bank, N.A for borrowings of up to $750.0 million. On April 14, 2023, the Company entered into an agreement to amend and restate the credit facility to increase the borrowing capacity to $1.0 billion (as so amended and restated, the “2023 Revolving Credit Facility”). The 2023 Revolving Credit Facility has a 5-year term and a stated floating interest rate which equates to an adjusted term SOFR plus an applicable margin. The borrowings from the Revolving Loans will be used for general corporate purposes of the Company. The Company may prepay any borrowings at any time without premium or penalty. An unused commitment fee is payable quarterly based on unused balances at a rate that is based on the ratings of the Company’s senior unsecured long-term indebtedness. This annual rate was 0.175% at August 3, 2024.

As of August 3, 2024, the 2023 Revolving Credit Facility was undrawn and available for draw down through April 14, 2028.

The 2023 Revolving Credit Facility requires that the Company and its subsidiaries comply with covenants relating to customary matters. The covenants are consistent with the 2024 and 2026 Term Loan Agreement covenants discussed above.

As of August 3, 2024, the Company was in compliance with its debt covenants for the credit agreements discussed above.

2029 and 2033 Senior Unsecured Notes

On September 18, 2023, the Company completed an offering of (i) $500.0 million aggregate principal amount of the Company’s 5.750% Senior Notes due 2029 (the “2029 Senior Notes”) and (ii) $500.0 million aggregate principal amount of the Company’s 5.950% Senior Notes due 2033 (the “2033 Senior Notes”, and, together with the 2029 Senior Notes, the “2029 and 2033 Senior Notes”).

10

MARVELL TECHNOLOGY, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ‑ (Continued)

The 2029 Senior Notes have a 5.5-year term and mature on February 15, 2029 and the 2033 Senior Notes have a 10-year term and mature on September 15, 2033. The stated and effective interest rates for the 2029 Senior Notes are 5.750% and 5.891%, respectively. The stated and effective interest rates for the 2033 Senior Notes are 5.950% and 6.082%, respectively. The Company may redeem the 2029 and 2033 Senior Notes, in whole or in part, at any time prior to their maturity at the redemption prices set forth in 2029 and 2033 Senior Notes. In addition, upon the occurrence of a change of control repurchase event (which involves the occurrence of both a change of control and a ratings event involving the 2029 and 2033 Senior Notes being rated below investment grade), the Company will be required to make an offer to repurchase the 2029 and 2033 Senior Notes at a price equal to 101% of the principal amount of the notes, plus accrued and unpaid interest to, but excluding, the repurchase date. The indenture governing the 2029 and 2033 Senior Notes also contains certain limited covenants restricting the Company’s ability to incur certain liens, enter into certain sale and leaseback transactions and merge or consolidate with any other entity or convey, transfer or lease all or substantially all of the Company’s properties or assets to another person, which, in each case, are subject to certain qualifications and exceptions. As of August 3, 2024, the Company had $1.0 billion borrowings outstanding from 2029 and 2033 Senior Notes.

2026, 2028, and 2031 Senior Unsecured Notes

On April 12, 2021, the Company completed an offering of (i) $500.0 million aggregate principal amount of the Company’s 1.650% Senior Notes due 2026 (the “2026 Senior Notes”), (ii) $750.0 million aggregate principal amount of the Company’s 2.450% Senior Notes due 2028 (the “2028 Senior Notes”) and (iii) $750.0 million aggregate principal amount of the Company’s 2.950% Senior Notes due 2031 (the “2031 Senior Notes”, and, together with the 2026 Senior Notes and the 2028 Senior Notes, the “2026, 2028 and 2031 Senior Notes”). On October 8, 2021, the 2026, 2028 and 2031 Senior Notes issued on April 12, 2021 were exchanged for new notes. The terms of the new notes issued in the exchange are substantially identical to the notes issued in April 2021, except that the new notes are registered under the Securities Act of 1933, as amended (the “Securities Act”) and the transfer restrictions and registration rights applicable to the 2026, 2028 and 2031 Senior Notes issued in April 2021 do not apply to the new notes.

The 2026 Senior Notes have a 5-year term and mature on April 15, 2026, the 2028 Senior Notes have a 7-year term and mature on April 15, 2028, and the 2031 Senior Notes have a 10-year term and mature on April 15, 2031. The stated and effective interest rates for the 2026 Senior Notes are 1.650% and 1.839%, respectively. The stated and effective interest rates for the 2028 Senior Notes are 2.450% and 2.554%, respectively. The stated and effective interest rates for the 2031 Senior Notes are 2.950% and 3.043%, respectively. The Company may redeem the 2026, 2028 and 2031 Senior Notes, in whole or in part, at any time prior to their respective maturity at the redemption prices set forth in the indenture governing the 2026, 2028 and 2031 Senior Notes. In addition, upon the occurrence of a change of control repurchase event (which involves the occurrence of both a change of control and a ratings event involving the 2026, 2028 and 2031 Senior Notes being rated below investment grade), the Company will be required to make an offer to repurchase the 2026, 2028 and 2031 Senior Notes at a price equal to 101% of the principal amount of the notes, plus accrued and unpaid interest to, but excluding, the repurchase date. The indenture governing the 2026, 2028 and 2031 Senior Notes also contains certain limited covenants restricting the Company’s ability to incur certain liens, enter into certain sale and leaseback transactions and merge or consolidate with any other entity or convey, transfer or lease all or substantially all of the Company’s properties or assets to another person, which, in each case, are subject to certain qualifications and exceptions. As of August 3, 2024, the Company had $2.0 billion borrowings outstanding from 2026, 2028 and 2031 Senior Notes.

2023 and 2028 Senior Unsecured Notes

On June 22, 2018, the Company’s Bermuda-based parent company Marvell Technology Group, Ltd. (“MTG”) completed a public offering of (i) $500.0 million aggregate principal amount of 4.200% Senior Notes due 2023 (the “MTG 2023 Notes”) and (ii) $500.0 million aggregate principal amount of 4.875% Senior Notes due 2028 (the “MTG 2028 Notes” and, together with the MTG 2023 Notes, the “MTG Senior Notes”).

In April 2021, in conjunction with the Company’s U.S. domiciliation, the Company commenced Exchange Offers on April 19, 2021 for the outstanding $1.0 billion in aggregate principal amount of the MTG Senior Notes outstanding in exchange for corresponding senior notes to be issued by the Company’s U.S. domiciled parent MTI. MTI made an offer to (i) exchange any and all of the outstanding MTG 2023 Notes for up to an aggregate principal amount of $500.0 million of new 4.200% Senior Notes due 2023 issued by MTI (the “MTI 2023 Notes”) and to (ii) exchange any and all of the outstanding MTG 2028 Notes for up to an aggregate principal amount of $500.0 million of new 4.875% Senior Notes due 2028 issued by MTI (the “MTI 2028 Notes” and, together with the MTI 2023 Notes, the “MTI Senior Notes”). Each new series of MTI Senior Notes have the same interest rate, maturity date, redemption terms and interest payment dates and are subject to substantially similar covenants as the corresponding series of the MTG Senior Notes for which they were offered in exchange.

11

MARVELL TECHNOLOGY, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ‑ (Continued)

The settlement of the Exchange Offers occurred on May 4, 2021 with $433.9 million aggregate principal amount of the MTG 2023 Notes and $479.5 million aggregate principal amount of the MTG 2028 Notes. The exchange was accounted for as a debt modification in accordance with applicable accounting guidance. On December 16, 2021, the MTI Senior Notes issued on May 4, 2021 were exchanged for new notes. The terms of the new notes issued in the exchange are substantially identical to the notes issued in May 2021, except that the new notes are registered under the Securities Act and the transfer restrictions and registration rights applicable to the MTI Senior Notes issued in May 2021 do not apply to the new notes.

The MTI 2023 Notes and MTG 2023 Notes with aggregate principal of $500.0 million matured on June 22, 2023 and was repaid.

The MTI 2028 Notes mature on June 22, 2028. The stated and effective interest rates for the MTI 2028 Notes are 4.875% and 4.988%, respectively. The Company may redeem the MTI Senior Notes, in whole or in part, at any time prior to their maturity at the redemption prices set forth in MTI Senior Notes. In addition, upon the occurrence of a change of control repurchase event (which involves the occurrence of both a change of control and a ratings event involving the MTI Senior Notes being rated below investment grade), the Company will be required to make an offer to repurchase the MTI Senior Notes at a price equal to 101% of the principal amount of the notes, plus accrued and unpaid interest to, but excluding, the repurchase date. The indenture governing the MTI Senior Notes also contains certain limited covenants restricting the Company’s ability to incur certain liens, enter into certain sale and leaseback transactions and merge or consolidate with any other entity or convey, transfer or lease all or substantially all of the Company’s properties or assets to another person, which, in each case, are subject to certain qualifications and exceptions.

The MTG 2028 Notes mature on June 22, 2028. The stated and effective interest rates for the MTG 2028 Notes are 4.875% and 4.940%, respectively. The Company may redeem the MTG Senior Notes, in whole or in part, at any time prior to their maturity at the redemption prices set forth in MTG Senior Notes.

As of August 3, 2024, the Company had $499.9 million borrowings outstanding from MTI 2028 Notes and MTG 2028 Notes.

Interest Expense and Future Contractual Maturities

During the three and six months ended August 3, 2024, the Company recognized $46.5 million and $93.3 million of interest expense in its unaudited condensed consolidated statements of operations related to interest, amortization of debt issuance costs and accretion of discount associated with the outstanding debt.

During the three and six months ended July 29, 2023, the Company recognized $51.9 million and $102.4 million of interest expense in its unaudited condensed consolidated statements of operations related to interest, amortization of debt issuance costs and accretion of discount associated with the outstanding debt.

As of August 3, 2024, the aggregate future contractual maturities of the Company’s outstanding debt, at face value, are as follows (in millions):

Fiscal YearAmount
Remainder of 2025$65.6 
2026131.2 
2027959.4 
2028 
20291,249.9 
Thereafter1,750.0 
Total $4,156.1 

Note 5. Commitments and Contingencies

Warranty Obligations

The Company generally warrants that its products sold to its customers will conform to its approved specifications and be free from defects in material and workmanship under normal use and conditions for one year. The Company may offer a longer warranty period in limited situations based on product type and negotiated warranty terms with certain customers.
12

MARVELL TECHNOLOGY, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ‑ (Continued)

Commitments

The Company’s commitments primarily consist of wafer purchase obligations with foundry partners, supply capacity reservation payment commitments with foundries and test & assembly partners, and technology license fee obligations.

Total future unconditional purchase commitments as of August 3, 2024, are as follows (in millions):

Fiscal Year
Purchase Commitments to Foundries and Test & Assembly Partners
Technology License Fees
Remainder of 2025$773.5 $56.5 
2026179.2 87.4 
2027157.3 56.3 
2028141.6 57.4 
2029128.0 50.6 
Thereafter402.7 118.2 
Total unconditional purchase commitments$1,782.3 $426.4 

Technology license fees include the liabilities under agreements for technology licenses between the Company and various vendors.

Under the Company’s manufacturing relationships with its foundry partners, cancellation of outstanding purchase orders is allowed but requires payment of all costs and expenses incurred through the date of cancellation, and in some cases, may result in incremental fees, loss of amounts paid in advance, or loss of priority to reserved capacity for a period of time.

The Company entered into manufacturing supply capacity reservation agreements with foundries and test & assembly suppliers in prior fiscal years. Under these arrangements, the Company agreed to pay capacity fees or refundable deposits to the suppliers in exchange for reserved manufacturing production capacity over the term of the agreements, which ranges from 4 to 10 years. In addition, the Company committed to certain purchase levels that were in line with the capacity reserved. During the first and second quarters of fiscal 2025, the Company worked with its foundry and test & assembly suppliers to amend certain manufacturing supply capacity reservation agreements, which resulted in reducing the Company’s related purchase level commitments. The Company currently estimates that it has agreed to purchase level commitments of at least $970.0 million of wafers, substrates, and other manufacturing products for the remainder of fiscal 2025 through fiscal 2033 under the capacity reservation agreements. In addition, total fees and refundable deposits payable under these arrangements are $59.6 million for the remainder of fiscal 2025 through fiscal 2028. Such purchase commitments are summarized in the preceding table.

In September 2021, the Company entered into an IP licensing agreement with a vendor which provides complete access to the vendor’s IP portfolio for 10 years. The arrangement provides access to IP over the term of the contract, including existing IP, as well as IP in development, and to be developed in the future. The contract provides support and maintenance over the term of the contract as well. Aggregate fees of $354.0 million are payable quarterly over the contract term.

Contingencies and Legal Proceedings

The Company currently is, and may from time to time become, subject to claims, lawsuits, governmental inquiries, inspections or investigations and other legal proceedings (collectively, “Legal Matters”) arising in the course of its business. Such Legal Matters, even if not meritorious, could result in the expenditure of significant financial and managerial resources.

13

MARVELL TECHNOLOGY, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ‑ (Continued)

The Company is currently unable to predict the final outcome of its pending Legal Matters and therefore cannot determine the likelihood of loss or estimate a range of possible loss, except with respect to amounts where it has determined a loss is both probable and estimable and has made an accrual. The Company evaluates, at least on a quarterly basis, developments in its Legal Matters that could affect the amount of any accrual, as well as any developments that would result in a loss contingency to become both probable and reasonably estimable. The ultimate outcome of a Legal Matter involves judgments, estimates and inherent uncertainties. An unfavorable outcome in a Legal Matter could require the Company to pay damages or could prevent the Company from selling some of its products in certain jurisdictions. While the Company cannot predict with certainty the results of the Legal Matters in which it is currently involved, the Company does not expect that the ultimate costs to resolve these Legal Matters will individually or in the aggregate have a material adverse effect on its financial condition, however, there can be no assurance that the current or any future Legal Matters will be resolved in a manner that is not adverse to the Company’s business, financial statements, results of operations or cash flows.

In the second quarter of fiscal 2024, the Company recognized approximately $90.0 million of charges for product related claims; such claims were fully resolved in the fourth quarter of fiscal 2024.

Indemnities, Commitments and Guarantees

During its normal course of business, the Company has made certain indemnities, commitments and guarantees under which it may be required to make payments in relation to certain transactions. These indemnities may include indemnities for general commercial obligations, indemnities to various lessors in connection with facility leases for certain claims arising from such facility or lease, and indemnities to directors and officers of the Company to the maximum extent permitted under the laws of Delaware. In addition, the Company has contractual commitments to various customers, which could require the Company to incur costs to repair an epidemic defect with respect to its products outside of the normal warranty period if such defect were to occur. The duration of these indemnities, commitments and guarantees varies, and in certain cases, is indefinite. Some of these indemnities, commitments and guarantees do not provide for any limitation of the maximum potential future payments that the Company could be obligated to make. In general, the Company does not record any liability for these indemnities, commitments and guarantees in the accompanying unaudited condensed consolidated balance sheets as the amounts cannot be reasonably estimated and are not considered probable. The Company does, however, accrue for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable and estimable.

Intellectual Property Indemnification

In addition to the above indemnities, the Company has agreed to indemnify certain customers for claims made against the Company’s products where such claims allege infringement of third-party intellectual property rights, including, but not limited to, patents, registered trademarks, and/or copyrights. Under the aforementioned indemnification clauses, the Company may be obligated to defend the customer and pay for the damages awarded against the customer as well as the attorneys’ fees and costs under an infringement claim. The Company’s indemnification obligations generally do not expire after termination or expiration of the agreement containing the indemnification obligation. Generally, but not always, there are limits on and exceptions to the Company’s potential liability for indemnification. Historically the Company has not made significant payments under these indemnification obligations and the Company cannot estimate the amount of potential future payments, if any, that it might be required to make as a result of these agreements. The maximum potential amount of any future payments that the Company could be required to make under these indemnification obligations could be significant.

Note 6. Goodwill and Acquired Intangible Assets, Net

Goodwill

Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination. The carrying value of goodwill as of August 3, 2024 and February 3, 2024 was $11.6 billion.

14

MARVELL TECHNOLOGY, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ‑ (Continued)

Acquired Intangible Assets, Net

As of August 3, 2024 and February 3, 2024, net carrying amounts excluding fully amortized intangible assets were as follows (in millions, except for weighted-average remaining amortization period):

August 3, 2024
Gross Carrying AmountsAccumulated AmortizationNet Carrying AmountsWeighted-Average Remaining Amortization Period (Years)
Developed technologies$5,166.0 $(2,972.3)$2,193.7 3.7
Customer contracts and related relationships2,179.0 (1,355.4)823.6 2.8
Trade names50.0 (32.9)17.1 1.7
Total acquired amortizable intangible assets$7,395.0 $(4,360.6)$3,034.4 3.4
IPR&D429.0 — 429.0 n/a
Total acquired intangible assets$7,824.0 $(4,360.6)$3,463.4 

February 3, 2024
Gross Carrying AmountsAccumulated AmortizationNet Carrying AmountsWeighted-Average Remaining Amortization Period (Years)
Developed technologies$4,989.0 $(2,613.5)$2,375.5 3.8
Customer contracts and related relationships2,179.0 (1,191.5)987.5 3.3
Trade names50.0 (27.9)22.1 2.2
Total acquired amortizable intangible assets$7,218.0 $(3,832.9)$3,385.1 3.6
IPR&D619.0 — 619.0 n/a
Total acquired intangible assets$7,837.0 $(3,832.9)$4,004.1 

The intangible assets are amortized on a straight-line basis over the estimated useful lives, except for certain Cavium customer contracts and related relationships, which are amortized using an accelerated method of amortization over the expected customer lives, which more closely align with the pattern of realization of economic benefits expected to be obtained. The IPR&D will be accounted for as an indefinite-lived intangible asset and will not be amortized until the underlying project reaches technological feasibility and commercial production, at which point, the IPR&D is reclassified as an amortizable acquired intangible asset and amortized over the asset’s estimated useful life. Useful lives for these IPR&D projects are expected to range between 8 to 10 years. In the event the IPR&D is abandoned, the related assets will be written off.

Amortization expense for acquired intangible assets for the three and six months ended August 3, 2024 was $275.7 million and $540.6 million, respectively. Amortization expense for acquired intangible assets for the three and six months ended July 29, 2023 was $271.8 million and $541.8 million, respectively.

The following table presents the estimated future amortization expense of acquired amortizable intangible assets as of August 3, 2024 (in millions):

Fiscal YearAmount
Remainder of 2025$535.7 
20261,023.9 
2027858.7 
2028301.9 
2029138.2 
Thereafter176.0 
$3,034.4 
15

MARVELL TECHNOLOGY, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ‑ (Continued)

Note 7. Fair Value Measurements

Fair value is an exit price representing the amount that would be received in the sale of an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. As a basis for considering such assumptions, the accounting guidance establishes a three-tier value hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value:

Level 1 — Observable inputs that reflect quoted prices for identical assets or liabilities in active markets.
Level 2 — Other inputs that are directly or indirectly observable in the marketplace.
Level 3 — Unobservable inputs that are supported by little or no market activity.

The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value.

The Company’s Level 1 assets include marketable equity investments that are classified as other non-current assets and which are valued primarily using quoted market prices. The Company’s Level 2 assets include time deposits, as the market inputs used to value these instruments consist of market yield. In addition, forward contracts and the severance pay fund are classified within Level 2 of the fair value hierarchy as the valuation inputs are based on quoted prices and market observable data of similar instruments.
 
The tables below set forth, by level, the Company’s assets and liabilities that are measured at fair value on a recurring basis. The tables do not include assets and liabilities that are measured at historical cost or any basis other than fair value (in millions):

 Fair Value Measurements at August 3, 2024
 Level 1Level 2Level 3Total
Items measured at fair value on a recurring basis:
Assets
Cash equivalents:
Time deposits 63.2  63.2 
Other non-current assets:
Marketable equity investments6.2   6.2 
Severance pay fund 0.5  0.5 
Total assets$6.2 $63.7 $ $69.9 
Liabilities
Accrued liabilities:
Foreign currency forward contracts$ $0.4 $ $0.4 
Total liabilities$ $0.4 $ $0.4 

The carrying value of investments in non-marketable equity securities recorded to fair value on a non-recurring basis is adjusted for observable transactions for identical or similar investments of the same issuer or for impairment. These securities relate to equity investments in privately-held companies. These items measured at fair value on a non-recurring basis are classified as Level 3 in the fair value hierarchy because the value is estimated based on valuation methods using the observable transaction price at the transaction date and other unobservable inputs such as volatility, rights and obligations of the securities held. As of August 3, 2024 and February 3, 2024, non-marketable equity investments had a carrying value of $50.4 million and $45.8 million, respectively, and are included in other non-current assets in the Company’s unaudited condensed consolidated balance sheets.
16

MARVELL TECHNOLOGY, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ‑ (Continued)

 Fair Value Measurements at February 3, 2024
 Level 1Level 2Level 3Total
Items measured at fair value on a recurring basis:
Assets
Cash equivalents:
Time deposits$ $2.6 $ $2.6 
Prepaid expenses and other current assets:
Foreign currency forward contracts 1.2  1.2 
Other non-current assets:
Marketable equity investments9.3   9.3 
Severance pay fund 0.5  0.5 
Total assets$9.3 $4.3 $ $13.6 

Fair Value of Debt

The Company classified the 2026 Term Loan, 2026 Senior Notes, 2028 Senior Notes, 2029 Senior Notes, 2031 Senior Notes, and 2033 Senior Notes as Level 2 in the fair value measurement hierarchy. The carrying value of the 2026 Term Loan approximates its fair value as the 2026 Term Loan is carried at a market observable interest rate that resets periodically. The estimated aggregate fair value of the unsecured senior notes was $3.4 billion at August 3, 2024 and $3.3 billion at February 3, 2024, and were classified as Level 2 as there are quoted prices from less active markets for the notes. See “Note 4 – Debt” for additional information.

Note 8. Restructuring

The Company continuously evaluates its existing operations to increase operational efficiency, decrease costs and increase profitability. A restructuring plan was initiated during the first quarter of fiscal 2024 (the “Fiscal 2024 Plan”) to streamline the organization and optimize resources. Restructuring charges are mainly comprised of severance, other one-time termination benefits, impairment and write-off of purchased IP licenses, and other costs. The Company recorded restructuring and other related charges of $4.0 million and $8.1 million for the three and six months ended August 3, 2024, and $42.0 million and $101.9 million for the three and six months ended July 29, 2023 related to the Fiscal 2024 Plan. The Company expects these restructuring actions to be substantially completed by the end of fiscal 2025.

The following table presents details related to the restructuring related charges as presented in the unaudited condensed consolidated statements of operations (in millions):

Three Months Ended Six Months Ended
August 3,
2024
July 29,
2023
August 3,
2024
July 29,
2023
Employee severance$3.2 $18.7 $6.9 $66.1 
Impairment and write-off of assets
Purchased IP licenses 20.5  28.6 
Other0.8 2.8 1.2 7.2 
$4.0 $42.0 $8.1 $101.9 

Note 9. Income Tax

The Company’s tax provision for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, the Company makes a cumulative adjustment in such period. The Company’s quarterly tax provision, and estimate of its annual effective tax rate, is subject to variation due to several factors, including variability in accurately predicting its pre-tax income or loss and the mix of jurisdictions to which they relate, intercompany transactions, changes in tax laws, the applicability of special tax regimes, changes in how the Company does business, discrete items, and acquisitions, as well as the integration of such acquisitions.

17

MARVELL TECHNOLOGY, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ‑ (Continued)

The Company recorded income tax expense of $47.1 million and $64.9 million for the three and six months ended August 3, 2024, respectively. The Company’s estimated effective tax rate for the year differs from the U.S. statutory rate of 21% primarily due to a substantial portion of its earnings, or in some cases, losses being taxed or benefited at rates lower than the U.S. statutory rate, net of the impact of U.S. taxation of foreign operations, benefits from tax credits, and valuation allowance releases, as well as discrete tax benefits and expenses for excess deductions and deficiencies on stock-based compensation, respectively.

The Company operates under tax incentives in certain countries that may be extended and/or renewed if certain additional requirements are satisfied. The tax incentives are conditional upon meeting certain employment and investment thresholds. The benefit of the tax incentives on the Company’s earnings per share was approximately $0.02 per share and $0.03 per share for the three and six months ended August 3, 2024, respectively. The benefit of the tax incentives on the Company’s earnings per share was approximately $0.01 per share for the six months ended July 29, 2023. No tax benefit was recorded for the three months ended July 29, 2023.

The amount of unrecognized tax benefits could increase or decrease due to changes in tax law in various jurisdictions, the effects of income tax audits, and changes in the U.S. dollar as compared to foreign currencies within the next 12 months. Excluding these factors, the Company does not expect a material decrease to its uncertain tax positions as a result of the lapse of the statutes of limitations in various jurisdictions during the next 12 months.

Note 10. Net Loss Per Share

The Company reports both basic net loss per share, which is based on the weighted-average number of common stock outstanding during the period, and diluted net loss per share, which is based on the weighted-average number of common stock outstanding and potentially dilutive shares outstanding during the period.

The computations of basic and diluted net loss per share are presented in the following table (in millions, except per share amounts):

 Three Months EndedSix Months Ended
 August 3,
2024
July 29,
2023
August 3,
2024
July 29,
2023
Numerator:
Net loss$(193.3)$(207.5)$(408.9)$(376.4)
Denominator:
Weighted-average shares — basic865.7 860.9 865.4 858.8 
Effect of dilutive securities:
Stock-based awards    
Weighted-average shares — diluted865.7 860.9 865.4 858.8 
Net loss per share
       Basic$(0.22)$(0.24)$(0.47)$(0.44)
       Diluted$(0.22)$(0.24)$(0.47)$(0.44)

Potential dilutive securities include dilutive common stock from stock-based awards attributable to the assumed exercise of stock options, restricted stock units and employee stock purchase plan shares using the treasury stock method. Under the treasury stock method, potential common stock outstanding are not included in the computation of diluted net income per share if their effect is anti-dilutive.

Anti-dilutive potential shares are presented in the following table (in millions):

 Three Months EndedSix Months Ended
 August 3,
2024
July 29,
2023
August 3,
2024
July 29,
2023
Weighted-average shares outstanding:
Stock-based awards11.2 13.7 11.5 12.1 

18

MARVELL TECHNOLOGY, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ‑ (Continued)

Anti-dilutive potential shares from stock-based awards are excluded from the calculation of diluted earnings per share for all periods reported above because either their exercise price exceeded the average market price during the period or the stock-based awards were determined to be anti-dilutive based on applying the treasury stock method. Anti-dilutive potential shares from stock-based awards are excluded from the calculation of diluted earnings per share for the three and six months ended August 3, 2024 and July 29, 2023 due to the net losses reported in those periods.

Note 11. Supplemental Financial Information (in millions)

Consolidated Balance Sheets

Accounts Receivable, net

The Company sells certain of its trade accounts receivable on a non-recourse basis to a third-party financial institution pursuant to a factoring arrangement. The Company accounts for these transactions as sales of receivables and presents cash proceeds as cash provided by operating activities in the unaudited condensed consolidated statements of cash flows. After the sale of its trade accounts receivable, the Company will collect payment from the customer and remit it to the third-party financial institution. Total trade accounts receivable sold under the factoring arrangement were $226.3 million and $494.4 million for the three and six months ended August 3, 2024, respectively, of which $241.5 million remained subject to servicing by the Company as of August 3, 2024. Factoring fees for the sales of receivables were recorded in interest income and other, net and were not material.

August 3,
2024
February 3,
2024
Inventories:
Work-in-process$584.9 $523.8 
Finished goods232.9 340.6 
               Inventories$817.8 $864.4 

August 3,
2024
February 3,
2024
Property and equipment, net:
Machinery and equipment$1,448.9 $1,376.2 
Land, buildings, and leasehold improvements305.8 312.4 
Computer software124.4 116.5 
Furniture and fixtures33.5 31.7 
1,912.6 1,836.8 
Less: Accumulated depreciation(1,131.1)(1,080.8)
               Property and equipment, net$781.5 $756.0 

August 3,
2024
February 3,
2024
Other non-current assets:
Prepaid ship and debit$376.9 $547.6 
Technology licenses352.7 350.6 
Prepayments on supply capacity reservation agreements300.8 302.5 
Operating right-of-use assets216.9 203.6 
Non-marketable equity investments50.4 45.8 
Other52.5 56.8 
               Other non-current assets$1,350.2 $1,506.9 

19

MARVELL TECHNOLOGY, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS ‑ (Continued)

 August 3,
2024
February 3,
2024
Accrued liabilities:
Variable consideration estimates (1)$409.0 $610.7 
Technology license obligations67.6 105.7 
Accrued income taxes payable63.9 17.8 
Accrued interest payable43.6 41.3 
Lease liabilities - current portion40.9 39.4 
Deferred revenue39.2 43.2 
Accrued legal reserve36.9 76.5 
Deferred non-recurring engineering credits22.9 21.7 
Accrued warranty expense3.2 25.5 
Other36.6 51.1 
               Accrued liabilities$763.8 $1,032.9 

(1) Substantially all of the variable consideration estimate is comprised of the ship & debit accrual reserve, but also includes estimated customer returns, price discounts, price protection, rebates, and stock rotation programs.

August 3,
2024
February 3,
2024
Other non-current liabilities:
Technology license obligations$214.5 $196.5 
Lease liabilities - non-current 207.2 196.0 
Non-current income taxes payable 73.1 56.6 
Deferred tax liabilities35.2